Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Constanza, Bohle"'
Autor:
Matías Gálvez-Silva, Patricio Arros, Camilo Berríos-Pastén, Aura Villamil, Paula I. Rodas, Ingrid Araya, Rodrigo Iglesias, Pamela Araya, Juan C. Hormazábal, Constanza Bohle, Yahua Chen, Yunn-Hwen Gan, Francisco P. Chávez, Rosalba Lagos, Andrés E. Marcoleta
Publikováno v:
Biological Research, Vol 57, Iss 1, Pp 1-9 (2024)
Abstract Background The convergence of hypervirulence and carbapenem resistance in the bacterial pathogen Klebsiella pneumoniae represents a critical global health concern. Hypervirulent K. pneumoniae (hvKp) strains, frequently from sequence type 23
Externí odkaz:
https://doaj.org/article/80e8330192aa4889a2064a6fae394347
Autor:
Natalia Covarrubias, Constanza Bohle, Christian Lara, Julio Miranda, Carmen Hurtado, Mauricio Venegas
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100406- (2021)
Introduction: Hepatitis E virus (HEV) seroprevalence studies have great variability depending the test used. In 2015, with a manual ELISA method, we reported an anti-HEV IgG seroprevalence of 32.6% in patients evaluated for hepatitis. Recently, the f
Externí odkaz:
https://doaj.org/article/309e7a6ae5434f2390de1447e84dec88
Autor:
Paz Beatriz Tabilo Valenzuela, Gabriela Flores Balter, Gustavo Saint-Pierre Contreras, Daniel Conei Valencia, Catalina Moreno Calderón, Constanza Bohle Venegas, Marcia Guajardo Rivera, Francisco Silva Ojeda, Maria Jesus Vial Covarrubias
Publikováno v:
Life, Vol 12, Iss 4, p 534 (2022)
In December 2019, a case of atypical pneumonia was reported in Wuhan, China. It was named COVID-19 and caused by SARS-CoV-2. In a few months, scientific groups around the world developed vaccines to reduce the disease’s severity. The objective was
Externí odkaz:
https://doaj.org/article/a6d588374f3f4838bb9cc63d92a6ca10
Autor:
Natalia Covarrubias, Constanza Bohle, Christian Lara, Julio Miranda, Carmen Hurtado, Mauricio Venegas
Publikováno v:
Revista chilena de infectología. 38:716-719
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2afc8d927d8041f0b6adb4726ec065a
https://doi.org/10.4067/s0716-10182021000500716
https://doi.org/10.4067/s0716-10182021000500716
Autor:
Carmen Hurtado, Christian Lara, Natalia Covarrubias, Julio Miranda, Constanza Bohle, Mauricio Venegas
Publikováno v:
Annals of Hepatology, Vol 24, Iss, Pp 100406-(2021)
Introduction: Hepatitis E virus (HEV) seroprevalence studies have great variability depending the test used. In 2015, with a manual ELISA method, we reported an anti-HEV IgG seroprevalence of 32.6% in patients evaluated for hepatitis. Recently, the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef934d95935cd44627d90cf204dd01d3
http://www.sciencedirect.com/science/article/pii/S1665268121001058
http://www.sciencedirect.com/science/article/pii/S1665268121001058
Autor:
Natalia, Covarrubias, Constanza, Bohle, Christian, Lara, Julio, Miranda, Carmen, Hurtado, Mauricio, Venegas
Publikováno v:
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 38(5)
The determination of anti-hepatitis E virus antibodies (anti-HEV) has a high variability depending on the assay used. In 2015, with a manual ELISA method, we reported anti-HEV IgG seroprevalence of 32.6% in patients under hepatitis study. There are f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30d2daf73668aa0d286cf4699a7916fe
https://pubmed.ncbi.nlm.nih.gov/35506841
https://pubmed.ncbi.nlm.nih.gov/35506841